We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DENTSPLY (XRAY) Q2 Earnings Miss Estimates, Sales Fall Y/Y
Read MoreHide Full Article
DENTSPLY SIRONA Inc. (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #3 (Hold) but that could change following its second quarter 2017 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank stocks here.) We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 65 cents per share, which missed the Zacks Consensus Estimate by a penny and was lower than earnings of 76 cents in the year-ago quarter.
Revenues: DENTSPLY’s net sales decreased to $992.7 million from $1,022.0 million in the year-ago period. This also came below the Zacks Consensus Estimate of $1,004.0 million. Sales of the combined businesses fell 2.2% at constant currency (cc) basis.
Key Stats: Dental and Healthcare Consumables sales rose 3.0% year over year at cc, while Technologies fell 5.6% in the quarter.
Major Factors: U.S. business in the second quarter was negatively impacted by inventory reduction related to a change in distribution strategy in North America and lower equipment sales to end-users. The company expects adjusted EPS for full year 2017 in the range of $2.65 to $2.75 per diluted share.
Check back later for our full write up on this DENTSPLY earnings report later!
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DENTSPLY (XRAY) Q2 Earnings Miss Estimates, Sales Fall Y/Y
DENTSPLY SIRONA Inc. (XRAY - Free Report) is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Currently, this York, PA- based company carries a Zacks Rank #3 (Hold) but that could change following its second quarter 2017 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank stocks here.) We have highlighted some of the key details from the just-released announcement below:
Earnings: DENTSPLY reported adjusted earnings of 65 cents per share, which missed the Zacks Consensus Estimate by a penny and was lower than earnings of 76 cents in the year-ago quarter.
Revenues: DENTSPLY’s net sales decreased to $992.7 million from $1,022.0 million in the year-ago period. This also came below the Zacks Consensus Estimate of $1,004.0 million. Sales of the combined businesses fell 2.2% at constant currency (cc) basis.
Key Stats: Dental and Healthcare Consumables sales rose 3.0% year over year at cc, while Technologies fell 5.6% in the quarter.
DENTSPLY SIRONA Inc. Price and EPS Surprise
DENTSPLY SIRONA Inc. Price and EPS Surprise | DENTSPLY SIRONA Inc. Quote
Major Factors: U.S. business in the second quarter was negatively impacted by inventory reduction related to a change in distribution strategy in North America and lower equipment sales to end-users. The company expects adjusted EPS for full year 2017 in the range of $2.65 to $2.75 per diluted share.
Check back later for our full write up on this DENTSPLY earnings report later!
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>